Connect with us

Hi, what are you looking for?

press release

The antiviral drugs market is anticipated to grow at a CAGR

#antiviral #drugs #market #anticipated #grow #CAGR

London, Nov. 01, 2022 (GLOBE NEWSWIRE) — Roots Analysis has announced the addition of “Antiviral Drugs Market, 2022 – 2035” report to its list of offerings.

The recent COVID-19 pandemic has exposed the lack of effective antiviral therapeutics that can be used for the treatment of re-emerging or emerging viral diseases and has highlighted the need for the development of safe and effective novel antiviral therapeutics. With around 80 approved antiviral drugs, a promising development pipeline, and encouraging clinical trial results, the antiviral drugs market is likely to witness notable growth in the mid to long-term.

To order this 190+ page report, which features 85+ figures and 110+ tables, please visit

Key Market Insights

Around 80 antiviral drugs have been approved, till date, targeting several infectious diseases
Around 45% of the abovementioned therapeutics have been approved post 2011. Majority of the approved antiviral drugs (~75%) are delivered via oral route of administration. Further, 50% of the drugs are approved for targeting HIV infection, followed by those approved for hepatitis (12%).

Around 430 antiviral drugs are currently being evaluated in clinical trials
Majority (~70%) of the aforementioned therapies are being evaluated in early stages of development (phase I, phase I/II and phase II). Further, around 45% of the drugs are being investigated as solid dosage forms (tablets and capsules).

Partnership activity has grown at an annualized rate of nearly 140%, between 2019-2022
Maximum number of partnerships were established in 2020 (104) and 2021 (82), which indicate the recent surge in the partnership activity in this domain. Majority of these (~20%) were clinical trial agreements. Further, most of the intercontinental, as well as intracontinental deals have been inked by the players based in North America.

Around USD 5.5 billion has been invested by both private and…

Read on GNW: The antiviral drugs market is anticipated to grow at a CAGR

You May Also Like


State would join dozens of others in enacting legislation based on federal government’s landmark whistleblower statute, the False Claims Act

press release

With a deep understanding of the latest tech, Erbo helps businesses flourish in a digital world.

press release

#Automotive #Carbon #Canister #Market #Projected #Hit #USD New York, US, Oct. 24, 2022 (GLOBE NEWSWIRE) —  According to a comprehensive research report by Market...

press release

Barrington Research Analyst James C.Goss reiterated an Outperform rating on shares of IMAX Corp IMAX with a Price target of $20. As theaters...